US Stock MarketDetailed Quotes
XTNT Xtant Medical
- 0.8500
- -0.0139-1.61%
Close May 3 16:00 ET
- 0.9000
- +0.0500+5.88%
Post 16:21 ET
110.68MMarket Cap85.00P/E (TTM)
0.9040High0.8300Low275.02KVolume0.8500Open0.8639Pre Close234.89KTurnover0.69%Turnover Ratio85.00P/E (Static)130.22MShares1.450052wk High2.16P/B33.76MFloat Cap0.600252wk Low--Dividend TTM39.72MShs Float1079.9991Historical High--Div YieldTTM8.57%Amplitude0.4291Historical Low0.8540Avg Price1Lot Size
About Xtant Medical Company
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
Company Profile
SymbolXTNT
Company NameXtant Medical
Listing DateMar 7, 2011
Founded2006
CEOMr. Sean E. Browne
MarketAMEX
Employees215
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address664 Cruiser Lane
CityBelgrade
ProvinceMontana
CountryUnited States of America
Zip Code59714
Phone1-406-388-0480
Websitehttp://www.xtantmedical.com
Company Executives
- Name
- Position
- Salary
- Sean E. Browne
- Director, President and Chief Executive Officer
- 1.06M
- Scott Neils
- Chief Financial Officer and Principal Accounting Officer
- 766.53K
- Mark A. Schallenberger
- Chief Operations Officer
- --
- Kevin D. Brandt
- Chief Commercial Officer
- 778.50K
- Stavros Vizirgianakis
- Chairman of the Board
- 155.72K
- Jonn R. Beeson
- Independent Director
- --
- John K. Bakewell
- Independent Director
- 194.52K
- Robert E. Mcnamara
- Independent Director
- 210.81K
- Lori D Mitchell-Keller
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg